Notice2022-12817
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 14, 2022
Issuing agencies
Defense Department
Abstract
The DoD is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (UFBAP) will take place.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 114 (Tuesday, June 14, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 114 (Tuesday, June 14, 2022)]
[Notices]
[Page 35974]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-12817]
[[Page 35974]]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal
Advisory Committee Meeting
AGENCY: Under Secretary of Defense for Personnel and Readiness,
Department of Defense (DoD).
ACTION: Notice of Federal Advisory Committee meeting.
-----------------------------------------------------------------------
SUMMARY: The DoD is publishing this notice to announce that the
following Federal Advisory Committee meeting of the Uniform Formulary
Beneficiary Advisory Panel (UFBAP) will take place.
DATES: Open to the public Thursday, June 30, 2022, 10:00 a.m.-1:00
p.m. (Eastern Standard Time).
ADDRESSES: The meeting will be held telephonically or via conference
call. The phone number for the remote access on June 30, 2022 is:
CONUS: 1-800-369-2046; OCONUS: 1-203-827-7030; PARTICIPANT CODE:
8546285.
These numbers and the dial-in instructions will also be posted on
the UFBAP website at: <a href="https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP">https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP</a>.
FOR FURTHER INFORMATION CONTACT: Designated Federal Official (DFO)
Colonel Paul J. Hoerner, USAF, 703-681-2890 (voice), <a href="/cdn-cgi/l/email-protection#402428216e2e23326e2a6d766e2d22386e2221303225313525333433002d21292c6e2d292c"><span class="__cf_email__" data-cfemail="c0a4a8a1eeaea3b2eeaaedf6eeada2b8eea2a1b0b2a5b1b5a5b3b4b380ada1a9aceeada9ac">[email protected]</span></a> (email). Mailing address is 7700 Arlington
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: <a href="https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP">https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP</a>. The most up-to-date changes to the meeting
agenda can be found on the website.
SUPPLEMENTARY INFORMATION: This meeting is being held under the
provisions of the Federal Advisory Committee Act (FACA) (5 U.S.C.,
Appendix) and 41 CFR 102-3.140 and 102-3.150.
Purpose of the Meeting: The UFBAP will review and comment on
recommendations made to the Director, Defense Health Agency, by the
Pharmacy and Therapeutics Committee, regarding the Uniform Formulary.
Agenda
1. 10:00 a.m.-10:10 a.m. Sign in for UFBAP members
2. 10:10 a.m.-10:40 a.m. Welcome and Opening Remarks
a. Welcome, Opening Remarks, and Introduction of UFBAP Members by
Col Paul J. Hoerner, DFO, UFBAP
b. Opening Remarks by UFBAP Co-Chair Senior Chief Petty Officer Jon
R. Ostrowski, Non-Commissioned Officers Association
c. Introductory Remarks by Dr. Edward VonBerg, Chief, Formulary
Management Branch
d. Public Written Comments by Dr. Edward VonBerg, Chief, Formulary
Management Branch
3. 10:40 a.m.-11:45 a.m. Scheduled Therapeutic Class Reviews
a. Diabetes Non-Insulin: Glucagon-Like Peptide-1 Receptor Agonists
(GLP1RAs) subclass
b. Migraine Agents: Oral Calcitonin Gene-Related Peptide (CGRPs)
Antagonists subclass
4. 11:45 a.m.-12:30 p.m. Newly Approved Drugs Review
5. 12:30 p.m.-12:45 p.m. Pertinent Utilization Management Issues
* Note that UFBAP discussion and vote will follow each section.
6. 12:45 p.m.-1:00 p.m. Closing remarks
a. Closing Remarks by UFBAP Co-Chair Senior Chief Petty Officer Jon
R. Ostrowski
b. Closing Remarks by Col Paul J Hoerner, DFO, UFBAP
Meeting Accessibility: Pursuant to section 10(a)(1) of the FACA and
41 CFR 102-3.140 through 102-3.165, and subject to the availability of
phone lines, this meeting is open to the public. Telephone lines are
limited and available to the first 220 people dialing in. There will be
220 lines total: 200 domestic and 20 international, including leader
lines.
Written Statements: Pursuant to 41 CFR 102-3.10, and section
10(a)(3) of FACA, interested persons or organizations may submit
written statements to the UFBAP about its mission and/or the agenda to
be addressed in this public meeting. Written statements should be
submitted to the UFBAP's DFO. The DFO's contact information can be
found in the FOR FURTHER INFORMATION CONTACT section of this notice.
Written comments or statements must be received by the UFBAP's DFO at
least five (5) calendar days prior to the meeting so they may be made
available to the UFBAP for its consideration prior to the meeting. The
DFO will review all submitted written statements and provide copies to
UFBAP.
Dated: June 9, 2022.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2022-12817 Filed 6-13-22; 8:45 am]
BILLING CODE 5001-06-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 14, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.